Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 2 75 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus NOVAMINE 8 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 2 75 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus NOVAMINE 8 5.
CLINIMIX 2.75/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER vs NOVAMINE 8.5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Parenteral nutrition providing amino acids for protein synthesis and dextrose for caloric support, bypassing gastrointestinal tract.
Novamine 8.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis and nitrogen balance in patients who cannot obtain adequate nutrition enterally.
Intravenous administration of 2.75% amino acids and 10% dextrose at a rate to provide 1-2 g protein/kg/day and 5-25 g dextrose/kg/day based on metabolic needs. Infusion rate not to exceed 0.5 g dextrose/kg/hour initially.
500 mL to 2000 mL intravenously per 24 hours, typically infused at a rate of 20 to 40 mL/hour; adjust based on metabolic and clinical response.
None Documented
None Documented
Not applicable; components are endogenously regulated (amino acids: minutes to hours; dextrose: ~1-2 hours). For continuous infusion, steady-state achieved within 4-6 hours.
Variable; amino acids have short t1/2 of minutes to hours. Clinical context: continuous infusion maintains steady state; elimination depends on metabolic demand and organ function.
Renal: ~50% as unchanged amino acids and dextrose metabolites within 6 hours; remainder metabolized to CO2 and H2O, eliminated via lungs and urine.
Renal: >95% as amino acids and metabolites. Biliary/fecal: <5%.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition